CD patients show increased CXCR3 expression on mononuclear cells in the inflamed mucosa [26] and IBD patients that test positive for MAP-specific IgG1 and IgG2 antibodies also show increased CXCR3 ligands in serum [27]. The gene discussed is CXCR3; the disease is inflammatory bowel disease.